KRAS G13D peptide, 25 mer

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

KRAS G13D peptide, 25 mer 

KRAS G13D peptide, 25 mer,KRAS 激活癌基因突变肽,是一种免疫增强剂。KRAS G13D peptide, 25 mer 可用于制备 KRAS 疫苗。详细信息请参考专利文献 WO2018144775A1。

KRAS G13D peptide, 25 mer

KRAS G13D peptide, 25 mer Chemical Structure

CAS No. : 145019-94-9

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

KRAS G13D peptide, 25 mer, a KRAS activating oncogene mutation peptide, is an immune potentiator extracted from patent WO2018144775A1. KRAS G13D peptide, 25 mer can be used to prepare KRAS vaccine[1].

体外研究
(In Vitro)

KRAS G13D peptide, 25 mer is encoded by immunomodulatory therapeutic mRNA that can be used to prepare KRAS vaccine[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

2634.10

Formula

C118H201N29O36S

CAS 号

145019-94-9

Sequence

Met-Thr-Glu-Tyr-Lys-Leu-Val-Val-Val-Gly-Ala-Gly-Asp-Val-Gly-Lys-Ser-Ala-Leu-Thr-Ile-Gln-Leu-Ile-Gln

Sequence Shortening

MTEYKLVVVGAGDVGKSALTIQLIQ

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Huang EYC, et, al. Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides. WO2018144775A1.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务